🇺🇸 FDA
Pipeline program

REKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen, Pre-filled pen containing 2.16mL solution, subcutaneous injection

Phase 2 small_molecule active

Quick answer

REKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen, Pre-filled pen containing 2.16mL solution, subcutaneous injection for Idiopathic male infertility (including oligoasthenozoospermia). is a Phase 2 program (small_molecule) at Ferring Pharmaceuticals A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Ferring Pharmaceuticals A/S
Indication
Idiopathic male infertility (including oligoasthenozoospermia).
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials